Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...

Agreement expands Cardio Diagnostics’ global footprint and supports improved detection and management of coronary heart disease in India. CHICAGO, January 07, 2026--(BUSINESS WIRE)--Cardio Diagnostics ...

Bengaluru: Dr. Lal Path Labs reported a ‍lower third-quarter profit on Friday after taking a one-time charge ⁠linked to India's new labour code, despite strong demand for its bundled test packages.

April 30 (Reuters) - Dr Lal Path Labs reported a 15.5% drop in fourth-quarter profit on Thursday, hurt by higher tax expenses. Here are some details: • Consolidated net profit fell to 1.31 billion ...

Risks remain around pricing pressure in a competitive diagnostics market, continued cost pressures, and execution risks in scaling newer segments ...

Dr Lal Path Labs Dividend 2026: The BSE 500 company on April 30 announced its Q4 quarterly earnings for financial year ...